A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/535 (2006.01) A61K 31/5377 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2334580
The present invention provides the use of a NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of bipolar disorder without concomitant therapy with other antidepressant or anti-anxiety agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
La présente invention concerne l'utilisation d'un antagoniste du récepteur NK-1 pour la fabrication d'un médicament, adapté à l'administration orale, destiné au traitement ou à la prévention de troubles bipolaires sans le besoin d'une thérapie simultanée à l'aide d'autres antidépresseurs ou d'anxiolytiques. L'invention concerne aussi des méthodes de traitement utilisant un tel antagoniste du récepteur NK-1 et des compositions pharmaceutiques le contenant.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of a nk-1 receptor antagonist for treating bipolar... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a nk-1 receptor antagonist for treating bipolar..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a nk-1 receptor antagonist for treating bipolar... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1889142